# A Study of Multiple Dosing Regimens of IV Conivaptan in Subjects With Euvolemic or Hypervolemic Hyponatremia

> **NCT00435591** · PHASE4 · COMPLETED · sponsor: **Cumberland Pharmaceuticals** · enrollment: 121 (actual)

## Conditions studied

- Hyponatremia
- Euvolemia
- Hypervolemia

## Interventions

- **DRUG:** Conivaptan
- **DRUG:** placebo

## Key facts

- **NCT ID:** NCT00435591
- **Lead sponsor:** Cumberland Pharmaceuticals
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2007-01
- **Primary completion:** 2008-09
- **Final completion:** 2008-09
- **Target enrollment:** 121 (ACTUAL)
- **Last updated:** 2014-05-15


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00435591

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00435591, "A Study of Multiple Dosing Regimens of IV Conivaptan in Subjects With Euvolemic or Hypervolemic Hyponatremia". Retrieved via AI Analytics 2026-05-25 from https://api.ai-analytics.org/clinical/NCT00435591. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*